Clinical Trial Update: TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing transarterial chemoembolization (TACE) with Adefovir versus TACE alone in patients with HBV-related unresectable hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Tongji University | Conditions: Hepatitis B Virus, Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN